CRISPR Therapeutics AG

CRSP

$199.88

+127.27% (1 year change)

Avg closing price

Price range

Market Cap

$10.6 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$148 Thousand

Total revenue in the last quarter.

Net Income

-$92.4 Million

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

-$3.29

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

-50.08x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$-92.4 Million

Earnings before interest expenses and taxes in the last quarter.

Employees

0

The number of full time employees.

Revenue & Earnings

Balance Sheet

CRISPR Therapeutics AG

News

CRISPR Therapeutics Has Soared in Just a Few Weeks - What to Do Now

CRISPR Therapeutics Has Soared in Just a Few Weeks - What to Do Now

This is a time to nail down profits….CRSP

The Street RealMoney The Street RealMoney, 2 days ago
Covid-19 Impact On CRISPR and CAS Gene Market Swot Analysis by Key Players: Caribou Biosciences Inc., CRISPR Therapeutics, Mirus Bio LLC, Editas Medicine, Takara Bio Inc., Synthego, Thermo Fisher Scientific

Covid-19 Impact On CRISPR and CAS Gene Market Swot Analysis by Key Players: Caribou Biosciences Inc., CRISPR Therapeutics, Mirus Bio LLC, Editas Medicine, Takara Bio Inc., Synthego, Thermo Fisher Scientific

COHERENT MARKET INSIGHTS has added a new report titled Global CRISPR and CAS Gene Market with analysis provides the insights which bring marketplace clearly into the focus and thus help organizatio...

OpenPR OpenPR, 5 days ago
Bradley J. Phd Bolzon Sells 33,000 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) Stock

Bradley J. Phd Bolzon Sells 33,000 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) Stock

CRISPR Therapeutics AG (NASDAQ:CRSP) Director Bradley J. Phd Bolzon sold 33,000 shares of the stock in a transaction on Thursday, December 10th. The stock was sold at an average price of $143.35, f...

Watchlist News Watchlist News, about 1 month ago